Cargando…
Antibody–drug conjugates harboring a kinesin spindle protein inhibitor with immunostimulatory properties
Antibody–drug conjugates (ADCs) are used to target cancer cells by means of antibodies directed to tumor-associated antigens, causing the incorporation of a cytotoxic payload into target cells. Here, we characterized the mode of action of ADC costing of a TWEAKR-specific monoclonal antibody conjugat...
Autores principales: | Sommer, Anette, Berndt, Sandra, Lerchen, Hans-Georg, Forveille, Sabrina, Sauvat, Allan, Mumberg, Dominik, Kroemer, Guido, Kepp, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837233/ https://www.ncbi.nlm.nih.gov/pubmed/35154909 http://dx.doi.org/10.1080/2162402X.2022.2037216 |
Ejemplares similares
-
IL3RA-Targeting Antibody–Drug Conjugate BAY-943 with a Kinesin Spindle Protein Inhibitor Payload Shows Efficacy in Preclinical Models of Hematologic Malignancies
por: Kirchhoff, Dennis, et al.
Publicado: (2020) -
Immunostimulatory effects of vitamin B5 improve anticancer immunotherapy
por: Bourgin, Melanie, et al.
Publicado: (2022) -
An unexpected link between immunogenic cell death and inhibition of gene transcription
por: Humeau, Juliette, et al.
Publicado: (2020) -
The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization
por: Zhou, Heng, et al.
Publicado: (2015) -
3,4-dimethoxychalcone induces autophagy and reduces neointimal hyperplasia and aortic lesions in mouse models of atherosclerosis
por: Cerrato, Giulia, et al.
Publicado: (2023)